ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: A report of the american college of cardiology foundation task force on expert consensus documents

Circulation

Volumn 121, Issue 22, 2010, Pages 2462-2508

  Hundley, W Gregory ^a   Bluemke, David A ^b   Finn, J Paul ^b   Flamm, Scott D ^c   Fogel, Mark A ^d   Friedrich, Matthias G ^c   Ho, Vincent B ^e,h   Jerosch Herold, Michael ^f   Kramer, Christopher M ^a   Manning, Warren J ^a   Patel, Manesh ^f   Pohost, Gerald M ^f   Stillman, Arthur E ^g   White, Richard D ^g   Woodard, Pamela K ^e   Harrington, Robert A ^f   Anderson, Jeffrey L ^f   Bates, Eric R ^f   Bridges, Charles R ^f   Eisenberg, Mark J ^f   Ferrari, Victor A ^f   Grines, Cindy L ^f   Hlatky, Mark A ^f   Jacobs, Alice K ^f   Kaul, Sanjay ^f   Lichtenberg, Robert C ^f   Lindner, Jonathan R ^f   Moliterno, David J ^f   Mukherjee, Debabrata ^f   Rosenson, Robert S ^f   Schofield, Richard S ^f   Shubrooks, Samuel J ^f   Stein, James H ^f   Tracy, Cynthia M ^f   Weitz, Howard H ^f   Wesley, Deborah J ^f   more..

^a AMERICAN COLLEGE OF CARDIOLOGY   (United States)

^b North American Society for Cardiovascular Imaging   (United States)

^c Society for Cardiovascular Magnetic Resonance   (United States)

^d AMERICAN ACADEMY OF PEDIATRICS   (United States)

^e American College of Radiology   (United States)

^f ACCF Task Force Liaison ^*

^g AMERICAN HEART ASSOCIATION   (United States)

^h UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

ACCF AHA Expert Consensus Document; Cardiovascular disease; Cardiovascular magnetic resonance; Magnetic resonance imaging; Safety

Indexed keywords

ADENOSINE; ATROPINE; DIPYRIDAMOLE; DOBUTAMINE; GADOLINIUM; TRACER;

ACUTE HEART INFARCTION; AMYLOIDOSIS; AORTA DISEASE; ARTERY DISEASE; ARTIFICIAL HEART PACEMAKER; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CAROTID ARTERY DISEASE; CONFERENCE PAPER; CONGENITAL HEART DISEASE; CONSENSUS DEVELOPMENT; CONSTRICTIVE PERICARDITIS; CORONARY ARTERY ANEURYSM; CORONARY ARTERY DISEASE; CORONARY STENT; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART HEMODYNAMICS; HEART VALVE PROSTHESIS; HEART VENTRICLE REMODELING; HEMOCHROMATOSIS; HUMAN; ISCHEMIC HEART DISEASE; LUNG ANGIOGRAPHY; MEDICAL DOCUMENTATION; METABOLISM; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SAFETY; PERICARDIAL DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY; VALVULAR HEART DISEASE; VIRUS MYOCARDITIS;

ADVISORY COMMITTEES; CARDIOLOGY; CARDIOVASCULAR DISEASES; FOUNDATIONS; HUMANS; MAGNETIC RESONANCE IMAGING; SOCIETIES, MEDICAL; UNITED STATES;

EID: 77953356206     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIR.0b013e3181d44a8f     Document Type: Conference Paper

References (426)

1. Saini S, Frankel RB, Stark DD, et al. Magnetism: a primer and review. AJR Am J Roentgenol. 1988;150:735-743
2. Pettigrew RI. Dynamic cardiac MR imaging: techniques and applications. Radiol Clin North Am. 1989;27:1183-1203
3. Hundley WG, Li HF, Willard JE, et al. Magnetic resonance imaging assessment of the severity of mitral regurgitation: comparison with invasive techniques. Circulation. 1995;92:1151-1158
4. Gandy SJ, Waugh SA, Nicholas RS, et al. Comparison of the reproduc-ibility of quantitative cardiac left ventricular assessments in healthy volunteers using different MRI scanners: a multicenter simulation. J Magn Reson Imaging. 2008;28:359-365
5. Edelman RR, Chien D, Kim D. Fast selective black blood MR imaging. Radiology. 1991;181:655-660
6. Haddad JL, Rofsky NM, Ambrosino MM, et al. T2-weighted MR imaging of the chest: comparison of electrocardiograph-triggered conventional and turbo spin-echo and nontriggered turbo spin-echo sequences. J Magn Reson Imaging. 1995;5:325-329
7. Simonetti OP, Finn JP, White RD, et al. "Black blood" T2-weighted inversion-recovery MR imaging of the heart. Radiology. 1996;199:49-57.
8. Stark DD, Higgins CB, Lanzer P, et al. Magnetic resonance imaging of the pericardium: normal and pathologic findings. Radiology. 1984;150: 469-474
9. Didier D, Saint-Martin C, Lapierre C, et al. Coarctation of the aorta: pre and postoperative evaluation with MRI and MR angiography; correlation with echocardiography and surgery. Int J Cardiovasc Imaging. 2006;22:457-475
10. Duerinckx AJ, Wexler L, Banerjee A, et al. Postoperative evaluation of pulmonary arteries in congenital heart surgery by magnetic resonance imaging: comparison with echocardiography. Am Heart J. 1994;128: 1139-1146
11. Nienaber CA, Rehders TC, Fratz S. Detection and assessment of congenital heart disease with magnetic resonance techniques. J Cardio-vasc Magn Reson. 1999;1:169-184
12. Nienaber CA, Spielmann RP, von Kodolitsch Y, et al. Diagnosis of thoracic aortic dissection: magnetic resonance imaging versus trans-esophageal echocardiography. Circulation. 1992;85:434-447
13. Nienaber CA, von Kodolitsch Y, Brockhoff CJ, et al. Comparison of conventional and transesophageal echocardiography with magnetic resonance imaging for anatomical mapping of thoracic aortic dissection: a dual noninvasive imaging study with anatomical and/or angiographic validation. Int J Card Imaging. 1994;10:1-14.
14. von Kodolitsch Y, Csosz SK, Koschyk DH, et al. Intramural hematoma of the aorta: predictors of progression to dissection and rupture. Circulation. 2003;107:1158-1163
15. Utz JA, Herfkens RJ, Heinsimer JA, et al. Valvular regurgitation: dynamic MR imaging. Radiology. 1988;168:91-94
16. Natori S, Lai S, Finn JP, et al. Cardiovascular function in multi-ethnic study of atherosclerosis: normal values by age, sex, and ethnicity. AJR Am J Roentgenol. 2006;186:S357-65.
17. Sechtem U, Pflugfelder PW, Gould RG, et al. Measurement of right and left ventricular volumes in healthy individuals with cine MR imaging. Radiology. 1987;163:697-702.
18. Semelka RC, Tomei E, Wagner S, et al. Normal left ventricular dimensions and function: interstudy reproducibility of measurements with cine MR imaging. Radiology. 1990;174:763-768
19. Semelka RC, Tomei E, Wagner S, et al. Interstudy reproducibility of dimensional and functional measurements between cine magnetic resonance studies in the morphologically abnormal left ventricle. Am Heart J. 1990;119:1367-1373
20. Barkhausen J, Ruehm SG, Goyen M, et al. MR evaluation of ventricular function: true fast imaging with steady-state precession versus fast low-angle shot cine MR imaging: feasibility study. Radiology. 2001; 219:264-269
21. Moon JC, Lorenz CH, Francis JM, et al. Breath-hold FLASH and FISP cardiovascular MR imaging: left ventricular volume differences and reproducibility. Radiology. 2002;223:789-797
22. Malayeri AA, Johnson WC, Macedo R, et al. Cardiac cine MRI: quantification of the relationship between fast gradient echo and steady-state free precession for determination of myocardial mass and volumes. J Magn Reson Imaging. 2008;28:60-66
23. Bloomer TN, Plein S, Radjenovic A, et al. Cine MRI using steady state free precession in the radial long axis orientation is a fast accurate method for obtaining volumetric data of the left ventricle. J Magn Reson Imaging. 2001;14:685-692
24. Bloomgarden DC, Fayad ZA, Ferrari VA, et al. Global cardiac function using fast breath-hold MRI: validation of new acquisition and analysis techniques. Magn Reson Med. 1997;37:683-692
25. Friedrich MG, Schulz-Menger J, Strohm O, et al. The diagnostic impact of 2D-versus 3D-left ventricular volumetry by MRI in patients with suspected heart failure. MAGMA. 2000;11:16-19
26. Bellenger NG, Davies LC, Francis JM, et al. Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2000;2:271-278
27. Bellenger NG, Burgess MI, Ray SG, et al. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radio-nuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? Eur Heart J. 2000;21:1387-1396
28. Grothues F, Smith GC, Moon JC, et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with 2-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol. 2002;90:29-34.
29. Grothues F, Moon JC, Bellenger NG, et al. Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance. Am Heart J. 2004;147:218-223
30. Pattynama PM, Lamb HJ, van der Velde EA, et al. Left ventricular measurements with cine and spin-echo MR imaging: a study of reproducibility with variance component analysis. Radiology. 1993;187:261-268
31. Axel L, Dougherty L. MR imaging of motion with spatial modulation of magnetization. Radiology. 1989;171:841-845
32. Zerhouni EA, Parish DM, Rogers WJ, et al. Human heart: tagging with MR imaging\a method for noninvasive assessment of myocardial motion. Radiology. 1988;169:59-63.
33. Edvardsen T, Rosen BD, Pan L, et al. Regional diastolic dysfunction in individuals with left ventricular hypertrophy measured by tagged magnetic resonance imaging\the Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J. 2006;151:109-114
34. Fernandes VR, Polak JF, Edvardsen T, et al. Subclinical atherosclerosis and incipient regional myocardial dysfunction in asymptomatic individuals: the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol. 2006;47:2420-2428 (Pubitemid 43866367)
35. Reichek N. MRI myocardial tagging. J Magn Reson Imaging. 1999;10: 609-616
36. Rosen BD, Lima JA, Nasir K, et al. Lower myocardial perfusion reserve is associated with decreased regional left ventricular function in asymptomatic participants of the multi-ethnic study of atherosclerosis. Circulation. 2006;114:289-297
37. Aletras AH, Ding S, Balaban RS, et al. DENSE: displacement encoding with stimulated echoes in cardiac functional MRI. J Magn Reson. 1999;137:247-252
38. Osman NF, Kerwin WS, McVeigh ER, et al. Cardiac motion tracking using CINE harmonic phase (HARP) magnetic resonance imaging. Magn Reson Med. 1999;42:1048-1060
39. Ingwall J. ATP and the Heart (Basic Science for the Cardiologist). Norwell, Mass: Kluwer Academic Publishers, 2002.
40. Firmin DN, Nayler GL, Kilner PJ, et al. The application of phase shifts in NMR for flow measurement. Magn Reson Med. 1990;14:230-241
41. Moran PR. A flow velocity zeugmatographic interlace for NMR imaging in humans. Magn Reson Imaging. 1982;1:197-203.
42. Hangiandreou NJ, Rossman PJ, Riederer SJ. Analysis of MR phase-contrast measurements of pulsatile velocity waveforms. J Magn Reson Imaging. 1993;3:387-394
43. Hundley WG, Li HF, Hillis LD, et al. Quantitation of cardiac output with velocity-encoded, phase-difference magnetic resonance imaging. Am J Cardiol. 1995;75:1250-1255
44. Markl M, Harloff A, Bley TA, et al. Time-resolved 3D MR velocity mapping at 3T: improved navigator-gated assessment of vascular anatomy and blood flow. J Magn Reson Imaging. 2007;25:824-831
45. Kuehne T, Yilmaz S, Steendijk P, et al. Magnetic resonance imaging analysis of right ventricular pressure-volume loops: in vivo validation and clinical application in patients with pulmonary hypertension. Circulation. 2004;110:2010-2016
46. Bogren HG, Buonocore MH, Follette DM. Four-dimensional aortic blood flow patterns in thoracic aortic grafts. J Cardiovasc Magn Reson. 2000;2:201-208
47. Caruthers SD, Lin SJ, Brown P, et al. Practical value of cardiac magnetic resonance imaging for clinical quantification of aortic valve stenosis: comparison with echocardiography. Circulation. 2003;108:2236-2243
48. Hundley WG, Li HF, Lange RA, et al. Assessment of left-to-right intracardiac shunting by velocity-encoded, phase-difference magnetic resonance imaging: a comparison with oximetric and indicator dilution techniques. Circulation. 1995;91:2955-2960
49. Weber OM, Higgins CB. MR evaluation of cardiovascular physiology in congenital heart disease: flow and function. J Cardiovasc Magn Reson. 2006;8:607-617
50. Kwong RY, Schussheim AE, Rekhraj S, et al. Detecting acute coronary syndrome in the emergency department with cardiac magnetic resonance imaging. Circulation. 2003;107:531-537
51. Pérez-Mayoral E, Negri V, Soler-Padrós J, et al. Chemistry of paramagnetic and diamagnetic contrast agents for Magnetic Resonance Imaging and Spectroscopy pH responsive contrast agents. Eur J Radiol. 2008; 67:453-458
52. Jahnke C, Nagel E, Gebker R, et al. Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation. 2007;115:1769-1776
53. Al-Saadi N, Nagel E, Gross M, et al. Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation. 2000;101:1379-1383
54. Cullen JH, Horsfield MA, Reek CR, et al. A myocardial perfusion reserve index in humans using first-pass contrast-enhanced magnetic resonance imaging. J Am Coll Cardiol. 1999;33:1386-1394
55. Nagel E, Klein C, Paetsch I, et al. Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation. 2003;108:432-437
56. Al-Saadi N, Nagel E, Gross M, et al. Improvement of myocardial perfusion reserve early after coronary intervention: assessment with cardiac magnetic resonance imaging. J Am Coll Cardiol. 2000;36:1557-1564
57. Fenchel M, Franow A, Stauder NI, et al. Myocardial perfusion after angioplasty in patients suspected of having single-vessel coronary artery disease: improvement detected at rest-stress first-pass perfusion MR imaging\initial experience. Radiology. 2005;237:67-74.
58. Lauerma K, Virtanen KS, Sipila LM, et al. Multislice MRI in assessment of myocardial perfusion in patients with single-vessel proximal left anterior descending coronary artery disease before and after revascular-ization. Circulation. 1997;96:2859-2867
59. Wu KC, Kim RJ, Bluemke DA, et al. Quantification and time course of microvascular obstruction by contrast-enhanced echocardiography and magnetic resonance imaging following acute myocardial infarction and reperfusion. J Am Coll Cardiol. 1998;32:1756-1764
60. Yan AT, Gibson CM, Larose E, et al. Characterization of microvascular dysfunction after acute myocardial infarction by cardiovascular magnetic resonance first-pass perfusion and late gadolinium enhancement imaging. J Cardiovasc Magn Reson. 2006;8:831-837
61. Bogaert J, Kalantzi M, Rademakers FE, et al. Determinants and impact of microvascular obstruction in successfully reperfused ST-segment elevation myocardial infarction: assessment by magnetic resonance imaging. Eur Radiol. 2007;17:2572-2580
62. Hombach V, Grebe O, Merkle N, et al. Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J. 2005;26:549-557
63. Wu KC, Zerhouni EA, Judd RM, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation. 1998;97:765-772
64. Tarantini G, Cacciavillani L, Corbetti F, et al. Duration of ischemia is a major determinant of transmurality and severe microvascular obstruction after primary angioplasty: a study performed with contrast-enhanced magnetic resonance. J Am Coll Cardiol. 2005;46:1229-1235
65. Schwitter J, Wacker CM, van Rossum AC, et al. MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J. 2008;29:480-489
66. Sakuma H, Suzawa N, Ichikawa Y, et al. Diagnostic accuracy of stress first-pass contrast-enhanced myocardial perfusion MRI compared with stress myocardial perfusion scintigraphy. AJR Am J Roentgenol. 2005; 185:95-102.
67. Schwitter J, Nanz D, Kneifel S, et al. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation. 2001;103:2230-2235
68. Wagner A, Mahrholdt H, Holly TA, et al. Contrast-enhanced MRI and routine single-photon emission computed tomography (SPECT) perfu-sion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet. 2003;361:374-379
69. Prakash A, Powell AJ, Krishnamurthy R, et al. Magnetic resonance imaging evaluation of myocardial perfusion and viability in congenital and acquired pediatric heart disease. Am J Cardiol. 2004;93:657-661
70. Koelemay MJ, Lijmer JG, Stoker J, et al. Magnetic resonance angiog-raphy for the evaluation of lower extremity arterial disease: a meta-analysis. JAMA. 2001;285:1338-1345
71. Nelemans PJ, Leiner T, de Vet HC, et al. Peripheral arterial disease: meta-analysis of the diagnostic performance of MR angiography. Radiology. 2000;217:105-114
72. Yucel EK, Anderson CM, Edelman RR, et al. AHA scientific statement: magnetic resonance angiography: update on applications for extracranial arteries. Circulation. 1999;100:2284-2301
73. Krinsky GA, Rofsky NM, DeCorato DR, et al. Thoracic aorta: comparison of gadolinium-enhanced three-dimensional MR angiography with conventional MR imaging. Radiology. 1997;202:183-193
74. Willerson JT, Scales F, Mukherjee A, et al. Abnormal myocardial fluid retention as an early manifestation of ischemic injury. Am J Pathol. 1977;87:159-188
75. Ingkanisorn WP, Kwong RY, Bohme NS, et al. Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain. J Am Coll Cardiol. 2006;47:1427-1432
76. Rehwald WG, Fieno DS, Chen EL, et al. Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation. 2002;105:224-229
77. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445-1453
78. Kwong RY, Chan AK, Brown KA, et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation. 2006;113:2733-2743
79. Maceira AM, Joshi J, Prasad SK, et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2005;111:186-193
80. Colucci WS, Braunwald E. Pathophysiology of heart failure. In: Zipes DP, Libby P, Bonow R, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. Philadelphia, Pa: Elsevier Saunders, 2005: 509-538
81. Hudsmith LE, Petersen SE, Francis JM, et al. Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging. J Cardiovasc Magn Reson. 2005;7:775-782
82. Gotte MJ, Germans T, Russel IK, et al. Myocardial strain and torsion quantified by cardiovascular magnetic resonance tissue tagging: studies in normal and impaired left ventricular function. J Am Coll Cardiol. 2006;48:2002-2011
83. Paelinck BP, de Roos A, Bax JJ, et al. Feasibility of tissue magnetic resonance imaging: a pilot study in comparison with tissue Doppler imaging and invasive measurement. J Am Coll Cardiol. 2005; 45:1109-1116
84. Abdel-Aty H, Zagrosek A, Schulz-Menger J, et al. Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation. 2004;109:2411-2416
85. Assomull RG, Prasad SK, Lyne J, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol. 2006;48:1977-1985
86. Maceira AM, Prasad SK, Khan M, et al. Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2006; 8:417-426
87. Castillo E, Osman NF, Rosen BD, et al. Quantitative assessment of regional myocardial function with MR-tagging in a multi-center study: interobserver and intraobserver agreement of fast strain analysis with Harmonic Phase (HARP) MRI. J Cardiovasc Magn Reson. 2005;7:783-791
88. McCrohon JA, Moon JC, Prasad SK, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation. 2003;108:54-59
89. Adabag AS, Maron BJ, Appelbaum E, et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol. 2008;51:1369-1374
90. Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation. 2004;109:1250-1258
91. Skouri HN, Dec GW, Friedrich MG, et al. Noninvasive imaging in myocarditis. J Am Coll Cardiol. 2006;48:2085-2093
92. Anderson LJ, Westwood MA, Prescott E, et al. Development of thalassaemic iron overload cardiomyopathy despite low liver iron levels and meticulous compliance to desferrioxamine. Acta Haematol. 2006; 115:106-108
93. Neubauer S, Horn M, Cramer M, et al. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomy-opathy. Circulation. 1997;96:2190-2196
94. Jung WI, Sieverding L, Breuer J, et al. 31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy. Circulation. 1998;97:2536-2542
95. Strohm O, Schulz-Menger J, Pilz B, et al. Measurement of left ventricular dimensions and function in patients with dilated cardiomy-opathy. J Magn Reson Imaging. 2001;13:367-371
96. Hunt SA, Abraham W, Chin M, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2005;46:e1-82.
97. Hendel RC, Patel MR, Kramer CM, et al. ACCF/ACR/SCCT/SCMR/ASNC/NASCI/ SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol. 2006;48: 1475-1497
98. Bunce NH, Lorenz CH, Keegan J, et al. Coronary artery anomalies: assessment with free-breathing three-dimensional coronary MR angiog-raphy. Radiology. 2003;227:201-208
99. Cheitlin MD, De Castro CM, McAllister HA. Sudden death as a complication of anomalous left coronary origin from the anterior sinus of Valsalva, a not-so-minor congenital anomaly. Circulation. 1974;50: 780-787
100. Gharib A, Ho V, Rosing D, et al. Coronary artery anomalies and variants: technical feasibility of assessment with coronary MR angiog-raphy at 3T. Radiology 2008;247:220-227. Abstract.
101. McConnell MV, Ganz P, Selwyn AP, et al. Identification of anomalous coronary arteries and their anatomic course by magnetic resonance coronary angiography. Circulation. 1995;92:3158-3162
102. Post JC, van Rossum AC, Bronzwaer JG, et al. Magnetic resonance angiography of anomalous coronary arteries. A new gold standard for delineating the proximal course? Circulation. 1995;92:3163-3171
103. Setser R, Arruda J, Weaver JA, et al. Exclusion of coronary artery anomalies in patients with congenital cardiovascular abnormalities using whole heart approach. J Cardiovasc Magn Reson 2007;9:128-129 Abstract.
104. Taylor AM, Thorne SA, Rubens MB, et al. Coronary artery imaging in grown up congenital heart disease: complementary role of magnetic resonance and X-ray coronary angiography. Circulation. 2000;101: 1670-1678
105. Vliegen HW, Doornbos J, de Roos A, et al. Value of fast gradient echo magnetic resonance angiography as an adjunct to coronary arteriography in detecting and confirming the course of clinically significant coronary artery anomalies. Am J Cardiol. 1997;79:773-776
106. Engel HJ, Torres C, Page HL Jr. Major variations in anatomical origin of the coronary arteries: angiographic observations in 4,250 patients without associated congenital heart disease. Cathet Cardiovasc Diagn. 1975;1:157-169
107. Pennell DJ, Sechtem U, Higgins C, et al. Clinical indications for cardiovascular magnetic resonance: consensus panel report 1. J Cardio-vasc Magn Reson. 2004;6:727-765 (Pubitemid 40041279)
108. Akagi T, Rose V, Benson LN, et al. Outcome of coronary artery aneurysms after Kawasaki disease. J Pediatr. 1992;121:689-694
109. Greil GF, Stuber M, Botnar RM, et al. Coronary magnetic resonance angiography in adolescents and young adults with Kawasaki disease. Circulation. 2002;105:908-911
110. Mavrogeni S, Papadopoulos G, Douskou M, et al. Magnetic resonance angiography is equivalent to X-ray coronary angiography for the evaluation of coronary arteries in Kawasaki disease. J Am Coll Cardiol. 2004;43:649-652
111. Mavrogeni S, Papadopoulos G, Douskou M, et al. Magnetic resonance angiography, function and viability evaluation in patients with Kawasaki disease. J Cardiovasc Magn Reson. 2006;8:493-498
112. Mavrogeni S, Manginas A, Papadakis E, et al. Correlation between magnetic resonance angiography (MRA) and quantitative coronary angiography (QCA) in ectatic coronary vessels. J Cardiovasc Magn Reson. 2004;6:17-23.
113. Bogaert J, Kuzo R, Dymarkowski S, et al. Coronary artery imaging with real-time navigator three-dimensional turbo-field-echo MR coronary angiography: initial experience. Radiology. 2003;226: 707-716
114. Botnar RM, Stuber M, Danias PG, et al. Improved coronary artery definition with T2-weighted, free-breathing, three-dimensional coronary MRA. Circulation. 1999;99:3139-3148
115. Dewey M, Teige F, Schnapauff D, et al. Combination of free-breathing and breathhold steady-state free precession magnetic resonance angiography for detection of coronary artery stenoses. J Magn Reson Imaging. 2006;23:674-681
116. Jahnke C, Paetsch I, Schnackenburg B, et al. Coronary MR angiography with steady-state free precession: individually adapted breath-hold technique versus free-breathing technique. Radiology. 2004;232:669-676
117. Jahnke C, Paetsch I, Nehrke K, et al. Rapid and complete coronary arterial tree visualization with magnetic resonance imaging: feasibility and diagnostic performance. Eur Heart J. 2005;26:2313-2319
118. Kim WY, Danias PG, Stuber M, et al. Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med. 2001;345:1863-1869 (Pubitemid 33716560)
119. Maintz D, Aepfelbacher FC, Kissinger KV, et al. Coronary MR angiography: comparison of quantitative and qualitative data from four techniques. AJR Am J Roentgenol. 2004;182:515-521
120. Ozgun M, Hoffmeier A, Kouwenhoven M, et al. Comparison of 3D segmented gradient-echo and steady-state free precession coronary MRI sequences in patients with coronary artery disease. AJR Am J Roentge-nol. 2005;185:103-109
121. Sakuma H, Ichikawa Y, Suzawa N, et al. Assessment of coronary arteries with total study time of less than 30 minutes by using whole-heart coronary MR angiography. Radiology. 2005;237:316-321
122. Sakuma H, Ichikawa Y, Chino S, et al. Detection of coronary artery stenosis with whole-heart coronary magnetic resonance angiography. J Am Coll Cardiol. 2006;48:1946-1950
123. Sommer T, Hofer U, Meyer C, et al. Submillimeter 3D coronary MR angiography with real-time navigator correction in 107 patients with suspected coronary artery disease. Rofo. 2002;174:459-466
124. Hauser T, Yeon SB, Appelbaum E, et al. Multimodality CMR detection of coronary artery disease in patients with heart failure and depressed systolic function: superiority of coronary MRI compared to late gadolinium enhancement. J Cardiovasc Magn Reson. 2009. Abstract in press.
125. Liu X, Zhao X, Huang J, et al. Comparison of 3D free-breathing coronary MR angiography and 64-MDCT angiography for detection of coronary stenosis in patients with high calcium scores. AJR Am J Roentgenol. 2007;189:1326-1332
126. Aurigemma GP, Reichek N, Axel L, et al. Noninvasive determination of coronary artery bypass graft patency by cine magnetic resonance imaging. Circulation. 1989;80:1595-1602
127. Engelmann MG, Knez A, von Smekal A, et al. Noninvasive coronary bypass graft imaging after multivessel revascularisation. Int J Cardiol. 2000;76:65-74.
128. Fitzgibbon GM, Kafka HP, Leach AJ, et al. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol. 1996;28:616-626
129. Goldman S, Copeland J, Moritz T, et al. Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy: results of a Veterans Administration Cooperative Study. Circulation. 1989;80:1190-1197
130. van Geuns RJ, Wielopolski PA, de Bruin HG, et al. MR coronary angiography with breath-hold targeted volumes: preliminary clinical results. Radiology. 2000;217:270-277
131. White RD, Caputo GR, Mark AS, et al. Coronary artery bypass graft patency: noninvasive evaluation with MR imaging. Radiology. 1987; 164:681-686
132. Langerak SE, Kunz P, Vliegen HW, et al. MR flow mapping in coronary artery bypass grafts: a validation study with Doppler flow measurements. Radiology. 2002;222:127-135
133. Langerak SE, Vliegen HW, Jukema JW, et al. Value of magnetic resonance imaging for the noninvasive detection of stenosis in coronary artery bypass grafts and recipient coronary arteries. Circulation. 2003; 107:1502-1508
134. Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina\summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol. 2003;41:159-168
135. Wilke N, Jerosch-Herold M, Wang Y, et al. Myocardial perfusion reserve: assessment with multisection, quantitative, first-pass MR imaging. Radiology. 1997;204:373-384
136. Schaefer S, van Tyen R, Saloner D. Evaluation of myocardial perfusion abnormalities with gadolinium-enhanced snapshot MR imaging in humans. Work in progress. Radiology. 1992;185:795-801.
137. Cury RC, Cattani CA, Gabure LA, et al. Diagnostic performance of stress perfusion and delayed-enhancement MR imaging in patients with coronary artery disease. Radiology. 2006;240:39-45.
138. Doyle M, Fuisz A, Kortright E, et al. The impact of myocardial flow reserve on the detection of coronary artery disease by perfusion imaging methods: an NHLBI WISE study. J Cardiovasc Magn Reson. 2003;5: 475-485
139. Giang TH, Nanz D, Coulden R, et al. Detection of coronary artery disease by magnetic resonance myocardial perfusion imaging with various contrast medium doses: first European multi-centre experience. Eur Heart J. 2004;25:1657-1665
140. Ishida N, Sakuma H, Motoyasu M, et al. Noninfarcted myocardium: correlation between dynamic first-pass contrast-enhanced myocardial MR imaging and quantitative coronary angiography. Radiology. 2003; 229:209-216
141. Kawase Y, Nishimoto M, Hato K, et al. Assessment of coronary artery disease with nicorandil stress magnetic resonance imaging. Osaka City Med J. 2004;50:87-94.
142. Klem I, Heitner JF, Shah DJ, et al. Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. J Am Coll Cardiol. 2006;47:1630-1638
143. Pilz G, Bernhardt P, Klos M, et al. Clinical implication of adenosine-stress cardiac magnetic resonance imaging as potential gatekeeper prior to invasive examination in patients with AHA/ACC class II indication for coronary angiography. Clin Res Cardiol. 2006;95:531-538
144. Plein S, Radjenovic A, Ridgway JP, et al. Coronary artery disease: myocardial perfusion MR imaging with sensitivity encoding versus conventional angiography. Radiology. 2005;235:423-430
145. Takase B, Nagata M, Kihara T, et al. Whole-heart dipyridamole stress first-pass myocardial perfusion MRI for the detection of coronary artery disease. Jpn Heart J. 2004;45:475-486
146. Nandalur KR, Dwamena BA, Choudhri AF, et al. Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis. J Am Coll Cardiol. 2007;50: 1343-1353
147. Wahl A, Paetsch I, Gollesch A, et al. Safety and feasibility of high-dose dobutamine-atropine stress cardiovascular magnetic resonance for diagnosis of myocardial ischaemia: experience in 1000 consecutive cases. Eur Heart J. 2004;25:1230-1236
148. Nagel E, Lehmkuhl HB, Bocksch W, et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardi-ography. Circulation. 1999;99:763-770
149. Hundley WG, Hamilton CA, Thomas MS, et al. Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echo-cardiography. Circulation. 1999;100:1697-1702
150. Baer FM, Smolarz K, Jungehulsing M, et al. Feasibility of high-dose dipyridamole-magnetic resonance imaging for detection of coronary artery disease and comparison with coronary angiography. Am J Cardiol. 1992;69:51-56
151. Baer FM, Voth E, Theissen P, et al. Coronary artery disease: findings with GRE MR imaging and Tc-99m-methoxyisobutyl-isonitrile SPECT during simultaneous dobutamine stress. Radiology. 1994;193:203-209
152. Jahnke C, Paetsch I, Gebker R, et al. Accelerated 4D dobutamine stress MR imaging with k-t BLAST: feasibility and diagnostic performance. Radiology. 2006;241:718-728
153. Paetsch I, Jahnke C, Wahl A, et al. Comparison of dobutamine stress magnetic resonance, adenosine stress magnetic resonance, and adeno-sine stress magnetic resonance perfusion. Circulation. 2004;110:835-842
154. Paetsch I, Jahnke C, Ferrari VA, et al. Determination of interobserver variability for identifying inducible left ventricular wall motion abnormalities during dobutamine stress magnetic resonance imaging. Eur Heart J. 2006;27:1459-1464
155. Pennell DJ, Underwood SR, Ell PJ, et al. Dipyridamole magnetic resonance imaging: a comparison with thallium-201 emission tomography. Br Heart J. 1990;64:362-369
156. Pennell DJ, Underwood SR, Manzara CC, et al. Magnetic resonance imaging during dobutamine stress in coronary artery disease. Am J Cardiol. 1992;70:34-40.
157. Rerkpattanapipat P, Gandhi SK, Darty SN, et al. Feasibility to detect severe coronary artery stenoses with upright treadmill exercise magnetic resonance imaging. Am J Cardiol. 2003;92:603-606
158. Schalla S, Klein C, Paetsch I, et al. Real-time MR image acquisition during high-dose dobutamine hydrochloride stress for detecting left ventricular wall-motion abnormalities in patients with coronary arterial disease. Radiology. 2002;224:845-851
159. van Rugge FP, van der Wall EE, de Roos A, et al. Dobutamine stress magnetic resonance imaging for detection of coronary artery disease. J Am Coll Cardiol. 1993;22:431-439
160. van Rugge FP, van der Wall EE, Spanjersberg SJ, et al. Magnetic resonance imaging during dobutamine stress for detection and localization of coronary artery disease. Quantitative wall motion analysis using a modification of the centerline method. Circulation. 1994;90:127-138
161. Kuijpers D, Ho KY, van Dijkman PR, et al. Dobutamine cardiovascular magnetic resonance for the detection of myocardial ischemia with the use of myocardial tagging. Circulation. 2003;107:1592-1597
162. Sayad DE, Willett DL, Hundley WG, et al. Dobutamine magnetic resonance imaging with myocardial tagging quantitatively predicts improvement in regional function after revascularization. Am J Cardiol. 1998;82:1149-1151
163. Buchthal SD, den Hollander JA, Merz CN, et al. Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms. N Engl J Med. 2000;342: 829-835
164. Weiss RG, Bottomley PA, Hardy CJ, et al. Regional myocardial metabolism of high-energy phosphates during isometric exercise in patients with coronary artery disease. N Engl J Med. 1990;323: 1593-1600
165. Johnson BD, Shaw LJ, Buchthal SD, et al. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation. 2004;109:2993-2999
166. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). J Am Coll Cardiol. 2004;44:e1-211.
167. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol. 2006;48:e247-e346.
168. Kim RJ, Lima JA, Chen EL, et al. Fast 23Na magnetic resonance imaging of acute reperfused myocardial infarction. Potential to assess myocardial viability. Circulation. 1997;95:1877-1885
169. Fieno DS, Kim RJ, Chen EL, et al. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol. 2000;36:1985-1991
170. Ibrahim T, Bulow HP, Hackl T, et al. Diagnostic value of contrast-enhanced magnetic resonance imaging and single-photon emission computed tomography for detection of myocardial necrosis early after acute myocardial infarction. J Am Coll Cardiol. 2007;49:208-216
171. Kumar A, Abdel-Aty H, Kriedemann I, et al. Contrast-enhanced cardiovascular magnetic resonance imaging of right ventricular infarction. J Am Coll Cardiol. 2006;48:1969-1976
172. Choi KM, Kim RJ, Gubernikoff G, et al. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation. 2001;104:1101-1107
173. Choi JW, Gibson CM, Murphy SA, et al. Myonecrosis following stent placement: association between impaired TIMI myocardial perfusion grade and MRI visualization of microinfarction. Catheter Cardiovasc Interv. 2004;61:472-476
174. Ricciardi MJ, Wu E, Davidson CJ, et al. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation. 2001;103:2780-2783
175. Steuer J, Bjerner T, Duvernoy O, et al. Visualisation and quantification of perioperative myocardial infarction after coronary artery bypass surgery with contrast-enhanced magnetic resonance imaging. Eur Heart J. 2004;25:1293-1299
176. Barbier CE, Bjerner T, Johansson L, et al. Myocardial scars more frequent than expected: magnetic resonance imaging detects potential risk group. J Am Coll Cardiol. 2006;48:765-771
177. Yan AT, Shayne AJ, Brown KA, et al. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation. 2006;114:32-39
178. Kramer CM. The prognostic significance of microvascular obstruction after myocardial infarction as defined by cardiovascular magnetic resonance. Eur Heart J. 2005;26:532-533
179. Reimer KA, Jennings RB. The changing anatomic reference base of evolving myocardial infarction: underestimation of myocardial collateral blood flow and overestimation of experimental anatomic infarct size due to tissue edema, hemorrhage and acute inflammation. Circulation. 1979;60:866-876
180. Rahimtoola SH. The hibernating myocardium. Am Heart J. 1989;117: 211-221
181. Lieberman AN, Weiss JL, Jugdutt BI, et al. Two-dimensional echocar-diography and infarct size: relationship of regional wall motion and thickening to the extent of myocardial infarction in the dog. Circulation. 1981;63:739-746
182. Rogers WJ Jr, Kramer CM, Geskin G, et al. Early contrast-enhanced MRI predicts late functional recovery after reperfused myocardial infarction. Circulation. 1999;99:744-750
183. Choi CJ, Haji-Momenian S, Dimaria JM, et al. Infarct involution and improved function during healing of acute myocardial infarction: the role of microvascular obstruction. J Cardiovasc Magn Reson. 2004;6: 917-925
184. Ingkanisorn WP, Rhoads KL, Aletras AH, et al. Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction. J Am Coll Cardiol. 2004;43:2253-2259
185. Schulz-Menger J, Abdel-Aty H, Busjahn A, et al. Left ventricular outflow tract planimetry by cardiovascular magnetic resonance differentiates obstructive from non-obstructive hypertrophic cardiomyopathy. J Cardiovasc Magn Reson. 2006;8:741-746
186. Moon JC, McKenna WJ, McCrohon JA, et al. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol. 2003;41:1561-1567
187. Matsunaka T, Hamada M, Matsumoto Y, et al. First-pass myocardial perfusion defect and delayed contrast enhancement in hypertrophic cardiomyopathy assessed with MRI. Magn Reson Med Sci. 2003;2: 61-69
188. Rickers C, Wilke NM, Jerosch-Herold M, et al. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomy-opathy. Circulation. 2005;112:855-861
189. Tandri H, Friedrich MG, Calkins H, et al. MRI of arrhythmogenic right ventricular cardiomyopathy/dysplasia. J Cardiovasc Magn Reson. 2004; 6:557-563 (Pubitemid 39277127)
190. Tandri H, Macedo R, Calkins H, et al. Role of magnetic resonance imaging in arrhythmogenic right ventricular dysplasia: insights from the North American arrhythmogenic right ventricular dysplasia (ARVD/C) study. Am Heart J. 2008;155:147-153
191. Jain A, Tandri H, Calkins H, et al. Role of cardiovascular magnetic resonance imaging in arrhythmogenic right ventricular dysplasia. J Car-diovasc Magn Reson. 2008;10:32.
192. Tandri H, Castillo E, Ferrari VA, et al. Magnetic resonance imaging of arrhythmogenic right ventricular dysplasia: sensitivity, specificity, and observer variability of fat detection versus functional analysis of the right ventricle. J Am Coll Cardiol. 2006;48:2277-2284
193. Tandri H, Saranathan M, Rodriguez ER, et al. Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol. 2005;45:98-103. (Pubitemid 40052034)
194. Sen-Chowdhry S, Prasad SK, Syrris P, et al. Cardiovascular magnetic resonance in arrhythmogenic right ventricular cardiomyopathy revisited: comparison with task force criteria and genotype. J Am Coll Cardiol. 2006;48:2132-2140
195. Sen-Chowdhry S, Syrris P, Ward D, et al. Clinical and genetic characterization of families with arrhythmogenic right ventricular dys-plasia/cardiomyopathy provides novel insights into patterns of disease expression. Circulation. 2007;115:1710-1720
196. Petersen SE, Selvanayagam JB, Wiesmann F, et al. Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol. 2005;46:101-105
197. Nazarian S, Bluemke DA, Lardo AC, et al. Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation. 2005;112:2821-2825
198. Abdel-Aty H, Boye P, Zagrosek A, et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol. 2005;45:1815-1822
199. Gutberlet M, Spors B, Thoma T, et al. Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistolog-ically detected inflammation and viral persistence. Radiology. 2008;246: 401-409
200. Liu PP, Yan AT. Cardiovascular magnetic resonance for the diagnosis of acute myocarditis: prospects for detecting myocardial inflammation. J Am Coll Cardiol. 2005;45:1823-1825
201. Friedrich M, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: a JACC white paper. J Am Coll Cardiol. 2009;53:1475-1487
202. Schulz-Menger J, Wassmuth R, Abdel-Aty H, et al. Patterns of myo-cardial inflammation and scarring in sarcoidosis as assessed by cardiovascular magnetic resonance. Heart. 2006;92:399-400.
203. Pennell DJ. T2* magnetic resonance and myocardial iron in thalassemia. Ann N Y Acad Sci. 2005;1054:373-378
204. Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001;22:2171-2179
205. Pereles FS, Kapoor V, Carr JC, et al. Usefulness of segmented TrueFISP cardiac pulse sequence in evaluation of congenital and acquired adult cardiac abnormalities. AJR Am J Roentgenol. 2001;177:1155-1160
206. Suzuki J, Caputo GR, Kondo C, et al. Cine MR imaging of valvular heart disease: display and imaging parameters affect the size of the signal void caused by valvular regurgitation. AJR Am J Roentgenol. 1990;155:723-727
207. Kupfahl C, Honold M, Meinhardt G, et al. Evaluation of aortic stenosis by cardiovascular magnetic resonance imaging: comparison with established routine clinical techniques. Heart. 2004;90:893-901.
208. Djavidani B, Debl K, Lenhart M, et al. Planimetry of mitral valve stenosis by magnetic resonance imaging. J Am Coll Cardiol. 2005;45: 2048-2053 (Pubitemid 40814130)
209. Djavidani B, Debl K, Buchner S, et al. MRI planimetry for diagnosis and follow-up of valve area in mitral stenosis treated with valvuloplasty. Rofo. 2006;178:781-786
210. Didier D, Ratib O, Lerch R, et al. Detection and quantification of valvular heart disease with dynamic cardiac MR imaging. Radiograph-ics. 2000;20:1279-1299
211. Dall'Armellina E, Hamilton CA, Hundley WG. Assessment of blood flow and valvular heart disease using phase-contrast cardiovascular magnetic resonance. Echocardiography. 2007;24:207-216
212. Eichenberger AC, Jenni R, von Schulthess GK. Aortic valve pressure gradients in patients with aortic valve stenosis: quantification with velocity-encoded cine MR imaging. AJR Am J Roentgenol. 1993;160: 971-977
213. Friedrich M, Schulz-Menger J, Dietz R. Magnetic resonance to assess the aortic valve area in aortic stenosis. J Am Coll Cardiol. 2004;43: 2148-2149
214. Fujita N, Chazouilleres AF, Hartiala JJ, et al. Quantification of mitral regurgitation by velocity-encoded cine nuclear magnetic resonance imaging. J Am Coll Cardiol. 1994;23:951-958
215. Gelfand EV, Hughes S, Hauser TH, et al. Severity of mitral and aortic regurgitation as assessed by cardiovascular magnetic resonance: optimizing correlation with Doppler echocardiography. J Cardiovasc Magn Reson. 2006;8:503-507
216. Sondergaard L, Lindvig K, Hildebrandt P, et al. Quantification of aortic regurgitation by magnetic resonance velocity mapping. Am Heart J. 1993;125:1081-1090
217. Helbing WA, Niezen RA, Le CS, et al. Right ventricular diastolic function in children with pulmonary regurgitation after repair of tetralogy of Fallot: volumetric evaluation by magnetic resonance velocity mapping. J Am Coll Cardiol. 1996;28:1827-1835
218. Akins EW, Slone RM, Wiechmann BN, et al. Perivalvular pseudoaneu-rysm complicating bacterial endocarditis: MR detection in five cases. AJR Am J Roentgenol. 1991;156:1155-1158
219. Araoz PA, Mulvagh SL, Tazelaar HD, et al. CT and MR imaging of benign primary cardiac neoplasms with echocardiographic correlation. Radiographics. 2000;20:1303-1319
220. Caduff JH, Hernandez RJ, Ludomirsky A. MR visualization of aortic valve vegetations. J Comput Assist Tomogr. 1996;20:613-615
221. Syed IS, Feng D, Harris SR, et al. MR imaging of cardiac masses. Magn Reson Imaging Clin N Am. 2008;16:137-164
222. Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease). J Am Coll Cardiol 2006;48:e1-148.
223. Lam KY, Dickens P, Chan AC. Tumors of the heart. A 20-year experience with a review of 12,485 consecutive autopsies. Arch Pathol Lab Med. 1993;117:1027-1031
224. Roberts WC. Primary and secondary neoplasms of the heart. Am J Cardiol. 1997;80:671-682
225. Gulati G, Sharma S, Kothari SS, et al. Comparison of echo and MRI in the imaging evaluation of intracardiac masses. Cardiovasc Intervent Radiol. 2004;27:459-469
226. Mollet NR, Dymarkowski S, Volders W, et al. Visualization of ventricular thrombi with contrast-enhanced magnetic resonance imaging in patients with ischemic heart disease. Circulation. 2002;106:2873-2876
227. Srichai MB, Junor C, Rodriguez LL, et al. Clinical, imaging, and pathological characteristics of left ventricular thrombus: a comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocar-diography, and transesophageal echocardiography with surgical or pathological validation. Am Heart J. 2006;152:75-84.
228. Weinsaft JW, Kim HW, Shah DJ, et al. Detection of left ventricular thrombus by delayed-enhancement cardiovascular magnetic resonance prevalence and markers in patients with systolic dysfunction. J Am Coll Cardiol. 2008;52:148-157
229. Simonetti OP, Kim RJ, Fieno DS, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology. 2001;218:215-223
230. Chiles C, Woodard PK, Gutierrez FR, et al. Metastatic involvement of the heart and pericardium: CT and MR imaging. Radiographics. 2001; 21:439-449
231. Sparrow PJ, Kurian JB, Jones TR, et al. MR imaging of cardiac tumors. Radiographics. 2005;25:1255-1276
232. Hoffmann U, Globits S, Schima W, et al. Usefulness of magnetic resonance imaging of cardiac and paracardiac masses. Am J Cardiol. 2003;92:890-895
233. Myers RB, Spodick DH. Constrictive pericarditis: clinical and patho-physiologic characteristics. Am Heart J. 1999;138:219-232
234. Sechtem U, Tscholakoff D, Higgins CB. MRI of the abnormal pericardium. AJR Am J Roentgenol. 1986;147:245-252
235. Soulen RL, Stark DD, Higgins CB. Magnetic resonance imaging of constrictive pericardial disease. Am J Cardiol. 1985;55:480-484
236. Talreja DR, Edwards WD, Danielson GK, et al. Constrictive pericarditis in 26 patients with histologically normal pericardial thickness. Circulation. 2003;108:1852-1857
237. Vaitkus PT, Kussmaul WG. Constrictive pericarditis versus restrictive cardiomyopathy: a reappraisal and update of diagnostic criteria. Am Heart J. 1991;122:1431-1441
238. Francone M, Dymarkowski S, Kalantzi M, et al. Real-time cine MRI of ventricular septal motion: a novel approach to assess ventricular coupling. J Magn Reson Imaging. 2005;21:305-309
239. Francone M, Dymarkowski S, Kalantzi M, et al. Assessment of ventricular coupling with real-time cine MRI and its value to differentiate constrictive pericarditis from restrictive cardiomyopathy. Eur Radiol. 2006;16:944-951
240. Santarone M, Corrado G, Belloni G. Effusive-constrictive pericarditis. Heart. 2000;83:551-556
241. Kojima S, Yamada N, Goto Y. Diagnosis of constrictive pericarditis by tagged cine magnetic resonance imaging. N Engl J Med. 1999;341: 373-374
242. Shabetai R, Fowler NO, Guntheroth WG. The hemodynamics of cardiac tamponade and constrictive pericarditis. Am J Cardiol. 1970;26:480-489
243. Hurrell DG, Nishimura RA, Higano ST, et al. Value of dynamic respiratory changes in left and right ventricular pressures for the diagnosis of constrictive pericarditis. Circulation. 1996;93:2007-2013
244. Hatle LK, Appleton CP, Popp RL. Differentiation of constrictive pericarditis and restrictive cardiomyopathy by Doppler echocardiogra-phy. Circulation. 1989;79:357-370
245. Fogel MA, Donofrio MT, Ramaciotti C, et al. Magnetic resonance and echocardiographic imaging of pulmonary artery size throughout stages of Fontan reconstruction. Circulation. 1994;90:2927-2936
246. Geva T, Vick GW 3rd, Wendt RE, et al. Role of spin echo and cine magnetic resonance imaging in presurgical planning of heterotaxy syndrome. Comparison with echocardiography and catheterization. Circulation. 1994;90:348-356
247. Beerbaum P, Korperich H, Barth P, et al. Noninvasive quantification of left-to-right shunt in pediatric patients: phase-contrast cine magnetic resonance imaging compared with invasive oximetry. Circulation. 2001; 103:2476-2482
248. Beerbaum P, Korperich H, Gieseke J, et al. Rapid left-to-right shunt quantification in children by phase-contrast magnetic resonance imaging combined with sensitivity encoding (SENSE). Circulation. 2003;108: 1355-1361
249. Pujadas S, Reddy GP, Weber O, et al. Phase contrast MR imaging to measure changes in collateral blood flow after stenting of recurrent aortic coarctation: initial experience. J Magn Reson Imaging. 2006;24: 72-76
250. Steffens JC, Bourne MW, Sakuma H, et al. Quantification of collateral blood flow in coarctation of the aorta by velocity encoded cine magnetic resonance imaging. Circulation. 1994;90:937-943
251. Fogel MA, Weinberg PM, Rychik J, et al. Caval contribution to flow in the branch pulmonary arteries of Fontan patients with a novel application of magnetic resonance presaturation pulse. Circulation. 1999;99: 1215-1221
252. Fogel MA, Durning S, Wernovsky G, et al. Brain versus lung: hierarchy of feedback loops in single ventricle patients with superior cavopulmo-nary connection. Circulation. 2004;110:II-152.
253. Rebergen SA, Chin JG, Ottenkamp J, et al. Pulmonary regurgitation in the late postoperative follow-up of tetralogy of Fallot. Volumetric quantitation by nuclear magnetic resonance velocity mapping. Circulation. 1993;88:2257-2266
254. van den Berg J, Hop WC, Strengers JL, et al. Clinical condition at mid-to-late follow-up after transatrial-transpulmonary repair of tetralogy of Fallot. J Thorac Cardiovasc Surg. 2007;133:470-477
255. Manning WJ, Wei JY, Fossel ET, et al. Measurement of left ventricular mass in rats using electrocardiogram-gated magnetic resonance imaging. Am J Physiol. 1990;258:H1181-6.
256. Markiewicz W, Sechtem U, Kirby R, et al. Measurement of ventricular volumes in the dog by nuclear magnetic resonance imaging. J Am Coll Cardiol. 1987;10:170-177 (Pubitemid 17092138)
257. Eicken A, Fratz S, Gutfried C, et al. Hearts late after Fontan operation have normal mass, normal volume, and reduced systolic function: a magnetic resonance imaging study. J Am Coll Cardiol. 2003;42:1061-1065
258. Fogel MA, Weinberg PM, Chin AJ, et al. Late ventricular geometry and performance changes of functional single ventricle throughout staged Fontan reconstruction assessed by magnetic resonance imaging. J Am Coll Cardiol. 1996;28:212-221
259. Jenkins NP, Ward C. Coarctation of the aorta: natural history and outcome after surgical treatment. QJM. 1999;92:365-371
260. Gerber BL, Coche E, Pasquet A, et al. Coronary artery stenosis: direct comparison of four-section multi-detector row CT and 3D navigator MR imaging for detection\initial results. Radiology. 2005;234:98-108.
261. Dewey M, Teige F, Schnapauff D, et al. Noninvasive detection of coronary artery stenoses with multislice computed tomography or magnetic resonance imaging. Ann Intern Med. 2006;145:407-415
262. Galjee MA, van Rossum AC, Doesburg T, et al. Value of magnetic resonance imaging in assessing patency and function of coronary artery bypass grafts. An angiographically controlled study. Circulation. 1996; 93:660-666
263. Molinari G, Sardanelli F, Zandrino F, et al. Value of navigator echo magnetic resonance angiography in detecting occlusion/patency of arterial and venous, single and sequential coronary bypass grafts. Int J Card Imaging. 2000;16:149-160
264. Wintersperger BJ, Engelmann MG, von Smekal A, et al. Patency of coronary bypass grafts: assessment with breath-hold contrast-enhanced MR angiography\value of a non-electrocardiographically triggered technique. Radiology. 1998;208:345-351
265. Wolff SD, Schwitter J, Coulden R, et al. Myocardial first-pass perfusion magnetic resonance imaging: a multicenter dose-ranging study. Circulation. 2004;110:732-737
266. Benz MG, Benz MW. Reduction of cancer risk associated with pediatric computed tomography by the development of new technologies. Pediatrics. 2004;114:205-209
267. Brenner D, Elliston C, Hall E, et al. Estimated risks of radiation-induced fatal cancer from pediatric CT. AJR Am J Roentgenol. 2001;176:289-296
268. Modan B, Keinan L, Blumstein T, et al. Cancer following cardiac catheterization in childhood. Int J Epidemiol. 2000;29:424-428
269. Wall BF. Radiation protection dosimetry for diagnostic radiology patients. Radiat Prot Dosimetry. 2004;109:409-419
270. National Cancer Institute. Radiation risks and pediatric computed tomography (CT): a guide for health care providers. Available at: http://www.cancer.gov/cancertopics/causes/radiation-risks-pediatric-CT. Accessed November 18, 2008.
271. Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). J Am Coll Cardiol. 2008;52:e1-121.
272. Stein PD, Woodard PK, Weg JG, et al. Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II Investigators. Radiology. 2007;242:15-21.
273. Stein PD, Woodard PK, Hull RD, et al. Gadolinium-enhanced magnetic resonance angiography for detection of acute pulmonary embolism: an in-depth review. Chest. 2003;124:2324-2328
274. Gupta A, Frazer CK, Ferguson JM, et al. Acute pulmonary embolism: diagnosis with MR angiography. Radiology. 1999;210:353-359 (Pubitemid 29055300)
275. Kluge A, Luboldt W, Bachmann G. Acute pulmonary embolism to the subsegmental level: diagnostic accuracy of three MRI techniques compared with 16-MDCT. AJR Am J Roentgenol. 2006;187: W7-14.
276. Meaney JF, Weg JG, Chenevert TL, et al. Diagnosis of pulmonary embolism with magnetic resonance angiography. N Engl J Med. 1997;336:1422-1427
277. Oudkerk M, van Beek EJ, Wielopolski P, et al. Comparison of contrast-enhanced magnetic resonance angiography and conventional pulmonary angiography for the diagnosis of pulmonary embolism: a prospective study. Lancet. 2002;359:1643-1647
278. Kluge A, Mueller C, Strunk J, et al. Experience in 207 combined MRI examinations for acute pulmonary embolism and deep vein thrombosis. AJR Am J Roentgenol. 2006;186:1686-1696
279. Stein PD, Fowler SE, Goodman LR, et al. Multidetector computed tomography for acute pulmonary embolism. N Engl J Med. 2006;354: 2317-2327
280. Evans AJ, Sostman HD, Witty LA, et al. Detection of deep venous thrombosis: prospective comparison of MR imaging and sonography. J Magn Reson Imaging. 1996;6:44-51.
281. Fraser DG, Moody AR, Morgan PS, et al. Diagnosis of lower-limb deep venous thrombosis: a prospective blinded study of magnetic resonance direct thrombus imaging. Ann Intern Med. 2002;136:89-98.
282. Laissy JP, Cinqualbre A, Loshkajian A, et al. Assessment of deep venous thrombosis in the lower limbs and pelvis: MR venography versus duplex Doppler sonography. AJR Am J Roentgenol. 1996;167:971-975
283. Hudsmith LE, Cheng AS, Tyler DJ, et al. Assessment of left atrial volumes at 1.5 Tesla and 3 Tesla using FLASH and SSFP cine imaging. J Cardiovasc Magn Reson. 2007;9:673-679
284. Jarvinen V, Kupari M, Hekali P, et al. Assessment of left atrial volumes and phasic function using cine magnetic resonance imaging in normal subjects. Am J Cardiol. 1994;73:1135-1138
285. Matsuoka H, Hamada M, Honda T, et al. Measurement of cardiac chamber volumes by cine magnetic resonance imaging. Angiology. 1993;44:321-327
286. Mohiaddin RH, Hasegawa M. Measurement of atrial volumes by magnetic resonance imaging in healthy volunteers and in patients with myocardial infarction. Eur Heart J. 1995;16:106-111
287. Rodevan O, Bjornerheim R, Ljosland M, et al. Left atrial volumes assessed by three-and two-dimensional echocardiography compared to MRI estimates. Int J Card Imaging. 1999;15:397-410.
288. Sievers B, Kirchberg S, Addo M, et al. Assessment of left atrial volumes in sinus rhythm and atrial fibrillation using the biplane area-length method and cardiovascular magnetic resonance imaging with TrueFISP. J Cardiovasc Magn Reson. 2004;6:855-863
289. Therkelsen SK, Groenning BA, Svendsen JH, et al. Atrial and ventricular volume and function in persistent and permanent atrial fibrillation, a magnetic resonance imaging study. J Cardiovasc Magn Reson. 2005;7:465-473
290. Ghaye B, Szapiro D, Dacher JN, et al. Percutaneous ablation for atrial fibrillation: the role of cross-sectional imaging. Radiographics. 2003;23 Spec No:S19-S33.
291. Dill T, Neumann T, Ekinci O, et al. Pulmonary vein diameter reduction after radiofrequency catheter ablation for paroxysmal atrial fibrillation evaluated by contrast-enhanced three-dimensional magnetic resonance imaging. Circulation. 2003;107:845-850
292. Kato R, Lickfett L, Meininger G, et al. Pulmonary vein anatomy in patients undergoing catheter ablation of atrial fibrillation: lessons learned by use of magnetic resonance imaging. Circulation. 2003;107: 2004-2010
293. Yang M, Akbari H, Reddy GP, et al. Identification of pulmonary vein stenosis after radiofrequency ablation for atrial fibrillation using MRI. J Comput Assist Tomogr. 2001;25:34-35
294. Arentz T, von Rosenthal J, Blum T, et al. Feasibility and safety of pulmonary vein isolation using a new mapping and navigation system in patients with refractory atrial fibrillation. Circulation. 2003;108:2484-2490
295. Dickfeld T, Calkins H, Zviman M, et al. Anatomic stereotactic catheter ablation on three-dimensional magnetic resonance images in real time. Circulation. 2003;108:2407-2413
296. Chen SA, Hsieh MH, Tai CT, et al. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofre-quency ablation. Circulation. 1999;100:1879-1886
297. Gerstenfeld EP, Guerra P, Sparks PB, et al. Clinical outcome after radiofrequency catheter ablation of focal atrial fibrillation triggers. J Cardiovasc Electrophysiol. 2001;12:900-908
298. Haissaguerre M, Jais P, Shah DC, et al. Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation. 2000;101:1409-1417
299. Shah DC, Haissaguerre M, Jais P, et al. Curative catheter ablation of paroxysmal atrial fibrillation in 200 patients: strategy for presentations ranging from sustained atrial fibrillation to no arrhythmias. Pacing Clin Electrophysiol. 2001;24:1541-1558
300. Kauczor HU, Kreitner KF. MRI of the pulmonary parenchyma. Eur Radiol. 1999;9:1755-1764
301. Kessler R, Fraisse P, Krause D, et al. Magnetic resonance imaging in the diagnosis of pulmonary infarction. Chest. 1991;99:298-300.
302. Peters DC, Wylie JV, Hauser TH, et al. Detection of pulmonary vein and left atrial scar after catheter ablation with three-dimensional navigator-gated delayed enhancement MR imaging: initial experience. Radiology. 2007;243:690-695
303. Mohrs OK, Nowak B, Petersen SE, et al. Thrombus detection in the left atrial appendage using contrast-enhanced MRI: a pilot study. AJR Am J Roentgenol. 2006;186:198-205.
304. Ohyama H, Hosomi N, Takahashi T, et al. Comparison of magnetic resonance imaging and transesophageal echocardiography in detection of thrombus in the left atrial appendage. Stroke. 2003;34:2436-2439
305. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiog-raphy and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease). J Am Coll Cardiol. 2006;47:e1-192.
306. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation. 2004;110:738-743
307. Baum RA, Rutter CM, Sunshine JH, et al. Multicenter trial to evaluate vascular magnetic resonance angiography of the lower extremity. American College of Radiology Rapid Technology Assessment Group. JAMA. 1995;274:875-880
308. Owen RS, Carpenter JP, Baum RA, et al. Magnetic resonance imaging of angiographically occult runoff vessels in peripheral arterial occlusive disease. N Engl J Med. 1992;326:1577-1581
309. Foo TK, Ho VB, Hood MN, et al. High-spatial-resolution multistation MR imaging of lower-extremity peripheral vasculature with segmented volume acquisition: feasibility study. Radiology. 2001;219:835-841
310. Ho KY, Leiner T, de Haan MW, et al. Peripheral vascular tree stenoses: evaluation with moving-bed infusion-tracking MR angiography. Radiology. 1998;206:683-692
311. Meaney JF, Ridgway JP, Chakraverty S, et al. Stepping-table gadolinium-enhanced digital subtraction MR angiography of the aorta and lower extremity arteries: preliminary experience. Radiology. 1999; 211:59-67.
312. Pereles FS, Collins JD, Carr JC, et al. Accuracy of stepping-table lower extremity MR angiography with dual-level bolus timing and separate calf acquisition: hybrid peripheral MR angiography. Radiology. 2006; 240:283-290
313. Andreisek G, Pfammatter T, Goepfert K, et al. Peripheral arteries in diabetic patients: standard bolus-chase and time-resolved MR angiogra-phy. Radiology. 2007;242:610-620
314. Hahn WY, Hecht EM, Friedman B, et al. Distal lower extremity imaging: prospective comparison of 2-dimensional time of flight, 3-dimensional time-resolved contrast-enhanced magnetic resonance an-giography, and 3-dimensional bolus chase contrast-enhanced magnetic resonance angiography. J Comput Assist Tomogr. 2007;31: 29-36.
315. Prince MR, Chabra SG, Watts R, et al. Contrast material travel times in patients undergoing peripheral MR angiography. Radiology. 2002;224: 55-61.
316. Ho VB, Corse WR. MR angiography of the abdominal aorta and peripheral vessels. Radiol Clin North Am. 2003;41:115-144
317. Leiner T, Kessels AG, Nelemans PJ, et al. Peripheral arterial disease: comparison of color duplex US and contrast-enhanced MR angiography for diagnosis. Radiology. 2005;235:699-708.
318. de Vries M, Ouwendijk R, Flobbe K, et al. Peripheral arterial disease: clinical and cost comparisons between duplex US and contrast-enhanced MR angiography\a multicenter randomized trial. Radiology. 2006;240: 401-410
319. Ouwendijk R, de Vries M, Pattynama PM, et al. Imaging peripheral arterial disease: a randomized controlled trial comparing contrast-enhanced MR angiography and multi-detector row CT angiography. Radiology. 2005;236:1094-1103
320. Sacks D, Bettmann M, Casciani T, et al. Expert panel on cardiovascular imaging: claudication appropriateness criteria 2005. Available at: http://www.acr.org/ac. Accessed June 30, 2008.
321. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med. 1991;325:445-453
322. Carr JC, Ma J, Desphande V, et al. High-resolution breath-hold contrast-enhanced MR angiography of the entire carotid circulation. AJR Am J Roentgenol. 2002;178:543-549
323. Yang CW, Carr JC, Futterer SF, et al. Contrast-enhanced MR angiog-raphy of the carotid and vertebrobasilar circulations. AJNR Am J Neuroradiol. 2005;26:2095-2101
324. Wright VL, Olan W, Dick B, et al. Assessment of CE-MRA for the rapid detection of supra-aortic vascular disease. Neurology. 2005;65:27-32.
325. Nael K, Villablanca JP, Pope WB, et al. Supraaortic arteries: contrast-enhanced MR angiography at 3.0 T\highly accelerated parallel acquisition for improved spatial resolution over an extended field of view. Radiology. 2007;242:600-609
326. Nael K, Villablanca JP, Saleh R, et al. Contrast-enhanced MR angiog-raphy at 3T in the evaluation of intracranial aneurysms: a comparison with time-of-flight MR angiography. AJNR Am J Neuroradiol. 2006; 27:2118-2121
327. Villablanca JP, Nael K, Habibi R, et al. 3 T contrast-enhanced magnetic resonance angiography for evaluation of the intracranial arteries: comparison with time-of-flight magnetic resonance angiography and multi-slice computed tomography angiography. Invest Radiol. 2006;41:799-805.
328. Oktar SO, Yucel C, Karaosmanoglu D, et al. Blood-flow volume quantification in internal carotid and vertebral arteries: comparison of 3 different ultrasound techniques with phase-contrast MR imaging. AJNR Am J Neuroradiol. 2006;27:363-369
329. Tanaka H, Fujita N, Enoki T, et al. Relationship between variations in the circle of Willis and flow rates in internal carotid and basilar arteries determined by means of magnetic resonance imaging with semiauto-mated lumen segmentation: reference data from 125 healthy volunteers. AJNR Am J Neuroradiol. 2006;27:1770-1775
330. Fayad ZA, Sirol M, Nikolaou K, et al. Magnetic resonance imaging and computed tomography in assessment of atherosclerotic plaque. Curr Atheroscler Rep. 2004;6:232-242 (Pubitemid 38898923)
331. Yuan C, Zhao XQ, Hatsukami TS. Quantitative evaluation of carotid atherosclerotic plaques by magnetic resonance imaging. Curr Athero-scler Rep. 2002;4:351-357
332. Fattori R, Nienaber CA. MRI of acute and chronic aortic pathology: preoperative and postoperative evaluation. J Magn Reson Imaging. 1999;10:741-750
333. Russo V, Renzulli M, Buttazzi K, et al. Acquired diseases of the thoracic aorta: role of MRI and MRA. Eur Radiol. 2006;16:852-865 (Pubitemid 43380245)
334. Schmidta M, Theissen P, Klempt G, et al. Long-term follow-up of 82 patients with chronic disease of the thoracic aorta using spin-echo and cine gradient magnetic resonance imaging. Magn Reson Imaging. 2000;18:795-806.
335. White RD, Higgins CB. Magnetic resonance imaging of thoracic vascular disease. J Thorac Imaging. 1989;4:34-50.
336. Gebker R, Gomaa O, Schnackenburg B, et al. Comparison of different MRI techniques for the assessment of thoracic aortic pathology: 3D contrast enhanced MR angiography, turbo spin echo and balanced steady state free precession. Int J Cardiovasc Imaging. 2007;23:747-756
337. Gaubert JY, Moulin G, Mesana T, et al. Type A dissection of the thoracic aorta: use of MR imaging for long-term follow-up. Radiology. 1995;196:363-369
338. Kawamoto S, Bluemke DA, Traill TA, et al. Thoracoabdominal aorta in Marfan syndrome: MR imaging findings of progression of vasculopathy after surgical repair. Radiology. 1997;203:727-732
339. Loubeyre P, Delignette A, Bonefoy L, et al. Magnetic resonance imaging evaluation of the ascending aorta after graft-inclusion surgery: comparison between an ultrafast contrast-enhanced MR sequence and conventional cine-MRI. J Magn Reson Imaging. 1996;6:478-483
340. Fayad ZA, Fallon JT, Shinnar M, et al. Noninvasive in vivo high-resolution magnetic resonance imaging of atherosclerotic lesions in genetically engineered mice. Circulation. 1998;98:1541-1547
341. Macura KJ, Szarf G, Fishman EK, et al. Role of computed tomography and magnetic resonance imaging in assessment of acute aortic syndromes. Semin Ultrasound CT MR. 2003;24:232-254
342. Troxler M, Mavor AI, Homer-Vanniasinkam S. Penetrating atherosclerotic ulcers of the aorta. Br J Surg. 2001;88:1169-1177
343. Salanitri GC, Huo E, Miller FH, et al. MRI of mycotic sinus of valsalva pseudoaneurysm secondary to Aspergillus pericarditis. AJR Am J Roentgenol. 2005;184:S25-7.
344. Givehchian M, Kramer U, Miller S, et al. Aortic root remodeling: functional MRI as an accurate tool for complete follow-up. Thorac Cardiovasc Surg. 2005;53:267-273
345. Weigel S, Tombach B, Maintz D, et al. Thoracic aortic stent graft: comparison of contrast-enhanced MR angiography and CT angiography in the follow-up: initial results. Eur Radiol. 2003;13:1628-1634
346. Suzuki T, Mehta RH, Ince H, et al. Clinical profiles and outcomes of acute type B aortic dissection in the current era: lessons from the International Registry of Aortic Dissection (IRAD). Circulation. 2003; 108 Suppl 1:II312-7.
347. Trimarchi S, Nienaber CA, Rampoldi V, et al. Role and results of surgery in acute type B aortic dissection: insights from the International Registry of Acute Aortic Dissection (IRAD). Circulation. 2006;114: I357-64.
348. Murray JG, Manisali M, Flamm SD, et al. Intramural hematoma of the thoracic aorta: MR image findings and their prognostic implications. Radiology. 1997;204:349-355
349. Oliver TB, Murchison JT, Reid JH. Serial MRI in the management of intramural haemorrhage of the thoracic aorta. Br J Radiol. 1997;70: 1288-1290
350. Sueyoshi E, Sakamoto I, Fukuda M, et al. Long-term outcome of type B aortic intramural hematoma: comparison with classic aortic dissection treated by the same therapeutic strategy. Ann Thorac Surg. 2004;78: 2112-2117
351. Ozkan U, Oguzkurt L, Tercan F, et al. Renal artery origins and variations: angiographic evaluation of 855 consecutive patients. Diagn Interv Radiol. 2006;12:183-186
352. Weizer AZ, Silverstein AD, Auge BK, et al. Determining the incidence of horseshoe kidney from radiographic data at a single institution. J Urol. 2003;170:1722-1726
353. Boatman DL, Cornell SH, Kolln CP. The arterial supply of horseshoe kidneys. Am J Roentgenol Radium Ther Nucl Med. 1971;113:447-451
354. Kramer U, Nael K, Laub G, et al. High-resolution magnetic resonance angiography of the renal arteries using parallel imaging acquisition techniques at 3.0 T: initial experience. Invest Radiol. 2006;41:125-132 (Pubitemid 44406209)
355. Nael K, Saleh R, Lee M, et al. High-spatial-resolution contrast-enhanced MR angiography of abdominal arteries with parallel acquisition at 3.0 T: initial experience in 32 patients. AJR Am J Roentgenol. 2006;187:W77-85.
356. Li A, Wong CS, Wong MK, et al. Acute adverse reactions to magnetic resonance contrast media\gadolinium chelates. Br J Radiol. 2006;79: 368-371
357. Dellegrottaglie S, Sanz J, Rajagopalan S. Technology insight: clinical role of magnetic resonance angiography in the diagnosis and management of renal artery stenosis. Nat Clin Pract Cardiovasc Med. 2006;3: 329-338
358. Michaely HJ, Schoenberg SO, Ittrich C, et al. Renal disease: value of functional magnetic resonance imaging with flow and perfusion measurements. Invest Radiol. 2004;39:698-705.
359. Kucher C, Steere J, Elenitsas R, et al. Nephrogenic fibrosing dermopa-thy/nephrogenic systemic fibrosis with diaphragmatic involvement in a patient with respiratory failure. J Am Acad Dermatol. 2006;54:S31-S34.
360. Kanal E, Barkovich AJ, Bell C, et al. ACR guidance document for safe MR practices: 2007. AJR Am J Roentgenol. 2007;188:1447-1474
361. Thomsen HS. Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide. Eur Radiol. 2006;16:2619-2621
362. Institute for Magnetic Resonance Safety, Education, and Research home page. Available at: http://www.MRIsafety.com. Accessed June 19, 2009.
363. ASTM International. Active Standard: ASTM F2503-08 standard practice for marking medical devices and other items for safety in the magnetic resonance environment. West Conshohocken, Pa: ASTM International; 2008.
364. Friedrich MG, Strohm O, Kivelitz D, et al. Behaviour of implantable coronary stents during magnetic resonance imaging. Int J Cardiovasc Intervent. 1999;2:217-222
365. Scott NA, Pettigrew RI. Absence of movement of coronary stents after placement in a magnetic resonance imaging field. Am J Cardiol. 1994;73:900-901
366. Shellock FG, Shellock VJ. Metallic stents: evaluation of MR imaging safety. AJR Am J Roentgenol. 1999;173:543-547
367. Syed MA, Carlson K, Murphy M, et al. Long-term safety of cardiac magnetic resonance imaging performed in the first few days after bare-metal stent implantation. J Magn Reson Imaging. 2006;24:1056-1061
368. Nehra A, Moran CJ, Cross DT III, et al. MR safety and imaging of neuroform stents at 3T. AJNR Am J Neuroradiol. 2004;25:1476-1478
369. Sommer T, Maintz D, Schmiedel A, et al. High field MR imaging: magnetic field interactions of aneurysm clips, coronary artery stents and iliac artery stents with a 3.0 Tesla MR system. Rofo. 2004;176:731-738
370. Gerber TC, Fasseas P, Lennon RJ, et al. Clinical safety of magnetic resonance imaging early after coronary artery stent placement. J Am Coll Cardiol. 2003;42:1295-1298
371. Porto I, Selvanayagam J, Ashar V, et al. Safety of magnetic resonance imaging one to three days after bare metal and drug-eluting stent implantation. Am J Cardiol. 2005;96:366-368
372. Rutledge JM, Vick GW III, Mullins CE, et al. Safety of magnetic resonance imaging immediately following Palmaz stent implant: a report of 3 cases. Catheter Cardiovasc Interv. 2001;53:519-523
373. Schroeder AP, Houlind K, Pedersen EM, et al. Magnetic resonance imaging seems safe in patients with intracoronary stents. J Cardiovasc Magn Reson. 2000;2:43-49
374. Shellock FG, Forder JR. Drug eluting coronary stent: in vitro evaluation of magnet resonance safety at 3 Tesla. J Cardiovasc Magn Reson. 2005;7:415-419
375. Patel MR, Albert TS, Kandzari DE, et al. Acute myocardial infarction: safety of cardiac MR imaging after percutaneous revascularization with stents. Radiology. 2006;240:674-680
376. Shellock FG. Reference manual for magnetic resonance safety, implants, and devices. 2006 ed. Los Angeles, Calif: Biomedical Research Publishing Group; 2006.
377. Graft SZ. Zenith Flex AAA endovascular graft MR information. Available at: http://www.cookmedical.com/ai/content/mmedia/FLX-MRINFO107.pdf. Accessed October 26, 2009.
378. Edwards MB, Taylor KM, Shellock FG. Prosthetic heart valves: evaluation of magnetic field interactions, heating, and artifacts at 1.5 T. J Magn Reson Imaging. 2000;12:363-369
379. Khambadkone S, Coats L, Taylor A, et al. Percutaneous pulmonary valve implantation in humans: results in 59 consecutive patients. Circulation. 2005;112:1189-1197
380. Shellock FG, Morisoli SM. Ex vivo evaluation of ferromagnetism, heating, and artifacts produced by heart valve prostheses exposed to a 1.5-T MR system. J Magn Reson Imaging. 1994;4:756-758
381. Shellock FG. Prosthetic heart valves and annuloplasty rings: assessment of magnetic field interactions, heating, and artifacts at 1.5 Tesla. J Cardiovasc Magn Reson. 2001;3:317-324
382. Shellock FG. Biomedical implants and devices: assessment of magnetic field interactions with a 3.0-Tesla MR system. J Magn Reson Imaging. 2002;16:721-732
383. Soulen RL, Budinger TF, Higgins CB. Magnetic resonance imaging of prosthetic heart valves. Radiology. 1985;154:705-707
384. Edwards MB, Draper ER, Hand JW, et al. Mechanical testing of human cardiac tissue: some implications for MRI safety. J Cardiovasc Magn Reson. 2005;7:835-840
385. Pruefer D, Kalden P, Schreiber W, et al. In vitro investigation of prosthetic heart valves in magnetic resonance imaging: evaluation of potential hazards. J Heart Valve Dis. 2001;10:410-414
386. Randall PA, Kohman LJ, Scalzetti EM, et al. Magnetic resonance imaging of prosthetic cardiac valves in vitro and in vivo. Am J Cardiol. 1988;62:973-976
387. Bock M, Mohrs OK, Voigtlaender T, et al. MRI safety aspects and artifacts of atrial septal defect and patent foramen ovale occluders at 1.5 tesla: a phantom study. Rofo. 2006;178:272-277
388. Shellock FG, Morisoli SM. Ex vivo evaluation of ferromagnetism and artifacts of cardiac occluders exposed to a 1.5-T MR system. J Magn Reson Imaging. 1994;4:213-215
389. Bartels LW, Bakker CJ, Viergever MA. Improved lumen visualization in metallic vascular implants by reducing RF artifacts. Magn Reson Med. 2002;47:171-180
390. Grassi CJ, Matsumoto AH, Teitelbaum GP. Vena caval occlusion after Simon nitinol filter placement: identification with MR imaging in patients with malignancy. J Vasc Interv Radiol. 1992;3:535-539
391. Kim D, Edelman RR, Margolin CJ, et al. The Simon nitinol filter: evaluation by MR and ultrasound. Angiology. 1992;43:541-548
392. Kiproff PM, Deeb ZL, Contractor FM, et al. Magnetic resonance characteristics of the LGM vena cava filter: technical note. Cardiovasc Intervent Radiol. 1991;14:254-255
393. Liebman CE, Messersmith RN, Levin DN, et al. MR imaging of inferior vena caval filters: safety and artifacts. AJR Am J Roentgenol. 1988;150: 1174-1176
394. Watanabe AT, Teitelbaum GP, Gomes AS, et al. MR imaging of the bird's nest filter. Radiology. 1990;177:578-579
395. Hartman J, Nguyen T, Larsen D, et al. MR artifacts, heat production, and ferromagnetism of Guglielmi detachable coils. AJNR Am J Neuroradiol. 1997;18:497-501.
396. Shellock FG, Detrick MS, Brant-Zawadski MN. MR compatibility of Guglielmi detachable coils. Radiology. 1997;203:568-570
397. Hennemeyer CT, Wicklow K, Feinberg DA, et al. In vitro evaluation of platinum Guglielmi detachable coils at 3 T with a porcine model: safety issues and artifacts. Radiology. 2001;219:732-737
398. Marshall MW, Teitelbaum GP, Kim HS, et al. Ferromagnetism and magnetic resonance artifacts of platinum embolization microcoils. Car-diovasc Intervent Radiol. 1991;14:163-166
399. Shellock FG, Gounis M, Wakhloo A. Detachable coil for cerebral aneurysms: in vitro evaluation of magnetic field interactions, heating, and artifacts at 3T. AJNR Am J Neuroradiol. 2005;26:363-366
400. Teitelbaum GP, Bradley WG Jr, Klein BD. MR imaging artifacts, ferromagnetism, and magnetic torque of intravascular filters, stents, and coils. Radiology. 1988;166:657-664
401. Hartnell GG, Spence L, Hughes LA, et al. Safety of MR imaging in patients who have retained metallic materials after cardiac surgery. AJR Am J Roentgenol. 1997;168:1157-1159
402. Faris OP, Shein MJ. Government viewpoint: U.S. Food and Drug Administration: Pacemakers, ICDs and MRI. Pacing Clin Electro-physiol. 2005;28:268-269
403. Hayes DL, Holmes DR Jr, Gray JE. Effect of 1.5 tesla nuclear magnetic resonance imaging scanner on implanted permanent pacemakers. J Am Coll Cardiol. 1987;10:782-786
404. Irnich W, Irnich B, Bartsch C, et al. Do we need pacemakers resistant to magnetic resonance imaging? Europace. 2005;7:353-365
405. Levine PA. Industry viewpoint: St. Jude Medical: Pacemakers, ICDs and MRI. Pacing Clin Electrophysiol. 2005;28:266-267
406. Prasad SK, Pennell DJ. Safety of cardiovascular magnetic resonance in patients with cardiovascular implants and devices. Heart. 2004;90: 1241-1244
407. Shellock FG, Tkach JA, Ruggieri PM, et al. Cardiac pacemakers, ICDs, and loop recorder: evaluation of translational attraction using conventional ("long-bore") and "short-bore" 1.5-and 3.0-Tesla MR systems. J Cardiovasc Magn Reson. 2003;5:387-397
408. Smith JM. Industry viewpoint: Guidant: Pacemakers, ICDs, and MRI. Pacing Clin Electrophysiol. 2005;28:264.
409. Avery JK. Loss prevention case of the month. Not my responsibility! J Tenn Med Assoc. 1988;81:523.
410. Martin ET, Coman JA, Shellock FG, et al. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. J Am Coll Cardiol. 2004;43: 1315-1324
411. Gimbel JR, Kanal E, Schwartz KM, et al. Outcome of magnetic resonance imaging (MRI) in selected patients with implantable cardioverter defibril-lators (ICDs). Pacing Clin Electrophysiol. 2005;28:270-273
412. Roguin A, Zviman MM, Meininger GR, et al. Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe: in vitro and in vivo assessment of safety and function at 1.5 T. Circulation. 2004;110:475-482
413. Del Ojo JL, Moya F, Villalba J, et al. Is magnetic resonance imaging safe in cardiac pacemaker recipients? Pacing Clin Electrophysiol. 2005;28:274-278
414. Gimbel JR, Johnson D, Levine PA, et al. Safe performance of magnetic resonance imaging on five patients with permanent cardiac pacemakers. Pacing Clin Electrophysiol. 1996;19:913-919
415. Goldsher D, Amikam S, Boulos M, et al. Magnetic resonance imaging for patients with permanent pacemakers: initial clinical experience. Isr Med Assoc J. 2006;8:91-94
416. Roguin A, Donahue JK, Bomma CS, et al. Cardiac magnetic resonance imaging in a patient with implantable cardioverter-defibrillator. Pacing Clin Electrophysiol. 2005;28:336-338
417. Sommer T, Vahlhaus C, Lauck G, et al. MR imaging and cardiac pacemakers: in-vitro evaluation and in-vivo studies in 51 patients at 0.5 T. Radiology. 2000;215:869-879
418. Gimbel JR, Kanal E. Can patients with implantable pacemakers safely undergo magnetic resonance imaging? J Am Coll Cardiol. 2004;43: 1325-1327
419. Martin ET. Can cardiac pacemakers and magnetic resonance imaging systems co-exist? Eur Heart J. 2005;26:325-327
420. Nazarian S, Roguin A, Zviman MM, et al. Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defi-brillators at 1.5 tesla. Circulation. 2006;114:1277-1284
421. Sommer T, Naehle CP, Yang A, et al. Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 tesla in the presence of cardiac pacemakers in non-pacemaker-dependent patients: a prospective study with 115 examinations. Circulation. 2006;114:1285-1292
422. Cowper SE, Su LD, Bhawan J, et al. Nephrogenic fibrosing dermopathy. Am J Dermatopathol. 2001;23:383-393
423. Ting WW, Stone MS, Madison KC, et al. Nephrogenic fibrosing dermopathy with systemic involvement. Arch Dermatol. 2003;139: 903-906
424. Mackay-Wiggan JM, Cohen DJ, Hardy MA, et al. Nephrogenic fibros-ing dermopathy (scleromyxedema-like illness of renal disease). J Am Acad Dermatol. 2003;48:55-60.
425. Sadowski EA, Bennett LK, Chan MR, et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology. 2007;243: 148-157
426. Perazella MA. Current status of gadolinium toxicity in patients with kidney disease. Clin J Am Soc Nephrol. 2009;4:461-469